On December 8, 2021, Nomic Bio, a Montréal-based protein-measuring platform company, announced its US$17 million Series A financing round led by Lux Capital. With this financing, Nomic Bio, formerly known as Nplex Biosciences, aims to build the world’s highest throughput protein-measuring platform. They also aim to improve human health by providing scientists with the tools they need to measure proteins at high resolution.
Lux Capital is a New York-based venture capital firm.
Osler, Hoskin & Harcourt LLP advised Lux Capital with a team consisting of Chad Bayne, Gary Marshall, and Jordana Corber-Tovel (Emerging & High Growth Companies).
Key Contact
Partner, Emerging and High Growth Companies, Toronto
Team
Partner, Emerging and High Growth Companies, Toronto
